The fenton activity of iron(III) in the presence of deferiprone

Journal of Pharmaceutical Sciences

Volumn 97, Issue 4, 2008, Pages 1454-1467

  Devanur, Lakshmi D ^a   Neubert, Hendrik ^a   Hider, Robert C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Analytical biochemistry; Chelation; Complexation; Structure; UV Vis spectroscopy

Indexed keywords

ASCORBIC ACID; DEFERIPRONE; DEOXYRIBOSE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IRON; IRON COMPLEX; EDETIC ACID; FENTON'S REAGENT; IRON CHELATING AGENT; PYRIDONE DERIVATIVE;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL ANALYSIS; COMPLEX FORMATION; FENTON REACTION; MASS SPECTROMETRY; CHEMISTRY; ELECTROSPRAY MASS SPECTROMETRY; OXIDATION REDUCTION REACTION;

ASCORBIC ACID; EDETIC ACID; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IRON; IRON CHELATING AGENTS; OXIDATION-REDUCTION; PYRIDONES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 43249092172     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21039     Document Type: Article

References (39)

1. Balfour JAB, Foster RH. 1999. Deferiprone: A review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases. Drugs 58:553-578.
2. Brittenham GM. 1992. Development of iron chelating agents for clinical use. Blood 80:569-574.
3. Hershko C. 1998. Iron chelators for thalassaemia. Br J Haematol 101:399-406.
4. Hoffbrand AV, Wonke B. 1997. Iron chelation therapy. J Intern Med Suppl 740:37-41.
5. Agarwal MB, Gupte SS, Viswanathan D, Vasandani D, Ramanathan J, Desai N, Puniyani RR, Chhablani AT. 1992. Long term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial. Br J Haematol 82:460-466.
6. Liu ZD,Hider RC. 2002. Design of clinically useful iron(III)-selective chelators. Med Res Rev 22:26-64.
7. Hider RC, Taylor PD, Walkinshaw M, Wang JL, Van der Helm D. 1990. Crystal structures of 3-hydroxy-1,2-dimethylpyridin-4-one: An iron(III) chelation study. J Chem Res 10:316-317.
8. Clarke ET, Martell AE, Reibenspies J. 1992. Crystal structure of the tris 1,2-dimethyl-3-hydroxy-4-pyridinone (DMHP) complex with the Fe(III) ion. Inorg Chim Acta 196:177-183.
9. Liu ZD, Hider RC. 2002. Design of iron chelators with therapeutic applications. Coord Chem Rev 232:151-171.
10. Hider RC, Kayyali R, Evans P. 1999. The production of hydroxyl radicals by deferiprone-iron compounds under physiological conditions. Blood 94S: 406a.
11. Neubert H, Hider RC, Cowan DA. 2002. Speciation of Fe(III)-chelate complexes by electrospray ionization ion trap and laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun Mass Spectrom 16: 1556-1561.
12. Merkofer M, Kissner R, Hider RC, Koppenol WH. 2004. Redox properties of the iron complexes of orally active chelators CP20, CP502, CP509 and I CL670. Helv Chim Acta 87:3021-3034.
13. 3: A pulse radiolysis study. Eur J Inorg Chem 2006:671-675.
14. Halliwell B, Gutteridge JM, Aruoma OI. 1987. The deoxyribose method: a simple "test-tube" assay for determination of rate constants for reactions of hydroxyl radicals. Anal Biochem 165:215-219.
15. Frei B, Yamamoto Y, Niclas D, Ames BN. 1988. Evaluation of an isoluminol chemiluminescence assay for the detection of hydroperoxides in human blood plasma. Anal Biochem 175:120-130.
16. Halliwell B, Gutteridge JMC. 1999. Free radicals in biology and medicine. Oxford: Oxford University Press. p 203.
17. Hicks M, Gebicki JM. 1986. Rate constants for reaction of hydroxyl radicals with Tris, Tricine and Hepes buffers. FEBS 199:92-94.
18. Alderighi L, Gans P, Ienco A, Peters D, Sabatini A, Vacca A. 1999. Hyperquad simulation and speciation (HySS): A utility program for the investigation of equilibria involving soluble and partially soluble species. Coord Chem Rev 184:311-318.
19. Baes CF, Mesmer RE. 1976. The hydrolysis of cations. New York: Wiley.
20. Motekaitis RJ, Martell AE. 1991. Stabilities of the iron(III) chelates of 1,2-dimethyl-3-hydroxy-4-pyridinone and related ligands. Inorg Chim Acta 183: 71-80.
21. 3+ values. J Med Chem 42:4814-4823.
22. 2O. J Am Chem Soc 120:13266-13267.
23. Finnen DC, Pinkerton AA, Dunham WR, Sands RH, Funk MO. 1991. Structures and spectroscopic characteristics of iron(III)diethylenetriaminepentaacetic acid complexes. A non-heme iron(III) complex with relevance to the iron environment in lipoxygenases. Inorg Chem 30:3960-3964.
24. Lind MD, Hamor MJ, Hamor TA, Hoard JL. 1964. Stereochemistry of ethylene diaminetetroaceto complexes. Inorg Chem 3:34-43.
25. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. 1989. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterisation by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 264:4417-4422.
26. Harrison P, Marwah SS, Hughes RT, Bareford D. 1994. Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy. J Clin Pathol 47:350-352.
27. Porter JB, Abeysinghe RD, Marshall L, Hider RC, Singh S. 1996. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood 88:705-713.
28. Caudle MT, Stevens RD, Crumbliss AL. 1994. Electrospray mass-spectrometry study of 1/1 ferric dihydroxamates. Inorg Chem 33:843-844.
29. Caudle MT, Stevens RD, Crumbliss AL. 1994. A monomer-to-dimer shift in a series of 1:1 ferric dihydroxamates probed by electrospray mass spectrometry. Inorg Chem 33:6111-6115.
30. Spasojevic I, Boukhalfa H, Stevens RD, Crumbliss AL. 2001. Aqueous solution speciation of Fe(III) complexes with dihydroxamate siderophores alcaligin and rhodotorulic acid and synthetic analogues using electrospray ionization mass spectrometry. Inorg Chem 40:49-58.
31. Minetti M, Forte T, Soriani M, Quaresima V, Menditto A, Ferrari M. 1992. Iron-induced ascorbate oxidation in plasma as monitored by ascorbate free radical formation. Biochem J 282:459-465.
32. Kontoghiorghes GJ, Goddard JG, Bartlett AN, Sheppard L. 1990. Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Clin Pharmacol Ther 48: 255-261.
33. Kuirmura Y, Ochiai R, Matsuura N. 1968. Oxygen oxidation of ferrous ions induced by chelation. Bull Chem Soc Jpn 41:2234-2239.
34. 3+. Inorg Chem 28: 3538-3545.
35. Martin RB. 1986. Citrate binding of Al3+ and Fe3+. J Inorg Biochem 28:181-187.
36. Goto K, Tamura H, Nagayama M. 1970. Mechanism of oxygenation of ferrous ion in neutral solution. Inorg Chem 9:963-964.
37. Harris DC, Aisen P. 1973. Facilitation of Fe(II) autoxidation by Fe(3) complexing agents. Biochim Biophys Acta 329:156-158.
38. Martell AE, Smith RM. 1974. Critical stability constants, Vol. 1. London: Plenum Press. p 206-207.
39. Ito S, Ishikawa Y, Nishino S, Kobayashi T, Ohba S, Nishida Y. 1998. Interaction between peroxide ion and phenol group which are coordinated to the same iron(III) ion. Polyhedron 17: 4379-4391.